We report two families in which neonatal haemochromatosis was observed in half sibs. In the first family, two successive girls were born of different fathers. In the second family, an affected brother and sister were followed by an affected half brother born after donor insemination. These observations, as well as a previous abstract describing two affected half sisters, revive the debate over the inheritance of neonatal haemochromatosis. Incomplete penetrance or gonadal mosaicism for a dominant disorder, a maternal "environmental factor", or mitochondrial defect may be more suitable explanations than autosomal recessive inheritance in this condition. Alternative modes of fertilisation, such as donor insemination or in vitro fertilisation with donor eggs, should be considered with caution. (JtMed Genet 1996;33:444-449) Key words: neonatal haemochromatosis; half sibs; maternal inheritance.
Abstract
We report two families in which neonatal haemochromatosis was observed in half sibs. In the first family, two successive girls were born of different fathers. In the second family, an affected brother and sister were followed by an affected half brother born after donor insemination. These observations, as well as a previous abstract describing two affected half sisters, revive the debate over the inheritance of neonatal haemochromatosis. Incom NH is thus established as a specific pathological diagnosis (that is, a phenotype) but its genetic or environmental (viral or toxic) bases are still unknown, no specific metabolic disorder is recognised, and aetiological heterogeneity is suspected. NH is usually considered as an autosomal recessive disorder (MIM 231 100). We report here on two sibships where typical neonatal haemochromatosis was observed in half sibs, indicating that at least in some instances NH should not be considered as a recessive disorder.
Case reports This female child was born to non-consanguineous, healthy, Belgian parents. An older sister was healthy. The pregnancy was uneventful and birth weight was 3500 g. From 4 hours of life, the child presented with diffuse mucosal bleeding and progressive jaundice. She rapidly deteriorated, with signs of liver insufficiency. On admission to a paediatric neonatal intensive care unit (NICU) on day 12, the child was deeply jaundiced, with ascites and a swollen abdomen. The liver and spleen could not be palpated. Bleeding diathesis was patent. Laboratory investigations showed: total bilirubin 243 iimol/l (normal < 17), direct bilirubin 92 iimol/l (normal <17), aspartate transaminase (AST) 52 IU/l (normal <25), alanine aminotransferase (ALT) 30 IU/l (normal <32), blood ammonium 95 gmol/l (normal: 18 to 59), prothrombin time 10% (normal >65%), blood glucose 0-9 mmol/l (normal >3 3). Despite intensive management, the child died on day 13 326 ,mol/l under treatment. However, serum iron increased to 228 itmol/l and liver insufficiency persisted. She had disseminated intravascular coagulation with fibrin degradation products at 160 gg/ml (normal <20).
In addition to standard treatment for liver failure, she was given continuous infusion factors II, V, VII, IX, and fibrinogen at a dosage of 50 IU/kg/day without improvement. Death resulted from massive intracranial haemorrhage and multivisceral failure on day 5.
Postmortem liver biopsy showed micronodular cirrhosis, mild ductular proliferation and portal inflammation, extramedullary haematopoiesis, and multinucleated hepatocytes. Iron overload was obvious and was concentrated in hepatocytes, without iron accumulation in Kupffer cells. Iron overload was found at necropsy in the pancreas, stomach, adrenal glands, kidneys, thyroid, heart, and salivary glands.
AETIOLOGICAL INVESTIGATIONS
As recommended elsewhere,8 appropriate blood and urine tests were performed before death in both children. Combined with postmortem pathological examination, tyrosinaemia, galactosaemia, hereditary fructose intolerance, organic acidaemias, Niemann-Pick type C, glycogenosis I, III, and IV, ocl antitrypsin deficiency, peroxisomal disorders, primary defects of bile acid synthesis, cystic fibrosis, Byler disease, Wolman disease, and neonatal infections were excluded. The mother was aged 22 at the birth of patient 1. Her liver function and basal iron metabolism, assessed six months after the birth of patient 2, showed slightly raised iron (2-04 mg/l, normal range 0 6-1 5) and transferrin (4-12 g/l, normal range from 2-4-3-8 1). On CT scan, attenuation of the liver was normal and the difference from splenic attenuation was not significant. Hepatic, renal, splenic, and adrenal iron storage, estimated through abdominal MRI scan, by TI, T2, and gradient echo sequences, was in the normal range. Striated muscle-liver signal ratio was higher than 1-6 in T2 and between 1-3 and 1-5 in Ti. Iron load was estimated as <50 tmol/kg. Chronic viral infection and autoimmune disorders were excluded.
Because of lack of proper material from patient 1, paternity testing could not be performed by DNA analysis. The parents were very concerned by the implications of maternal inheritance and accepted all investigations. We had the opportunity to discuss genetic aspects several times with the mother, alone or with her husband. The possibility of a single father was categorically excluded and, considering their involvement and distress, the author has no doubt about that statement. FAMILY 2 Patient 1 This boy was born at 39 weeks of gestation after a normal pregnancy. Birth weight was 2877 g, OFC 33-5 cm. He was noted to have spontaneously resolving hypoglycaemia on day 1. Jaundice appeared within 24 hours and severe conjugated hyperbilirubinaemia with signs of liver dysfunction was obvious by day 7. The liver remained non-palpable. Progressive hepatic failure and convulsive encephalopathy led to death at 5 weeks. Necropsy showed widespread liver fibrosis and biliary ductular proliferation, the latter containing bile in many places. Large amounts ofstainable iron pigment were present predominantly in the hepatocytes with the macrophages being less affected. A mild chronic lymphomonocytic inflammatory infiltrate was seen in the fibrous tissue. Considerable iron was also shown in the myocardium and a few renal tubular cells. Neither thyroid, adrenal, or other tissues examined showed iron. The pancreas was not available for examination. There was no other significant pathology except for severe brain swelling. Patient 
2
This girl, the sib of patient 1, was born by normal delivery with a birth weight of 1984 g. Intrauterine growth retardation had been diagnosed late in the pregnancy. She died on day 2 of overwhelming liver failure. Blood taken within the first day of life showed a serum iron within the normal range and a serum ferritin of 1270 mg/l (normal range up to 950 mg/l). A liver biopsy showed an identical picture to that ofher brother with severe destruction ofhepatic architecture and widespread fibrosis and loss of hepatocytes. There was extensive biliary transformation and hepatocytes contained much stored iron. Necropsy was refused.
Patient 3
Following genetic counselling, the couple was given a 1 in 4 risk of recurrence based on probable autosomal recessive inheritance. The parents decided to opt for artificial insemination by an anonymous donor (AID). A male infant with a birth weight of 2536 g was born after a normal pregnancy but died of fulminating liver disease on day 2. A liver biopsy showed an identical picture to that of his two half sibs. Necropsy was not performed. Paternity by donor was confirmed by a five multiallelic loci DNA probe analysis.
AETIOLOGICAL INVESTIGATIONS
Multiple investigations were undertaken on patients 1 and 2. Liver function became grossly disordered in patient 1 over the first seven days. There was raised aspartate transaminase (654 IU/l on day 1 and 1255 IU/l by day 8).
Alpha fetoprotein levels were grossly raised in patient 1 (>44 800IU/1). There was no evidence of haemolytic anaemia and no erythrophagocytosis on bone marrow biopsy. A sweat test and immunoglobulin estimation were normal. Metabolic screening excluded tyrosinaemia, galactosaemia, glutamic aciduria type 2, and Niemann-Pick disease type C. No fatty oxidation defects or inborn errors of bile acids were discovered, excluding most peroxisomal disorders. There was no evidence of a storage disorder and bone marrow and spleen specimens from the first child were normal. Mitochondrial DNA investigations showed no major deletions or any of the common mutations (MELAS, MERRF, and NARP). Viral studies including hepatitis B, CMV, rubella, and Coxsackie serology were normal. There was no evidence of toxoplasmosis or mycoplasma infection.
FAMILY HISTORY
The parents were healthy, non-consanguineous, and British, aged 29 at the birth of patient 1. Clinical examination was normal. Basal iron metabolism in the parents (serum iron, iron binding capacity, and ferritin) was normal other than low serum iron levels in the mother (9-5 gmol/l, normal range 14-31 ,umol/l). Liver function tests in both parents were normal other than minimally raised bilirubin levels in the father (25 itmol/l, normal range [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] ,umol/l). Basic metabolic screening (urea and creatinine, electrolytes, amino acids, caeruloplasmin) was all normal as were the karyotypes of both parents. Chronic immune/ infectious disorder was excluded in the mother, who in addition had normal glycosylation of transferrin.
Although its levels were normal, in the mother (1 2 g/l, normal range 1-2-2-6) and the father (1 * 3 g/l), a 1 antitrypsin phenotyping indicated that the mother was heterozygous for a new mutation which she had inherited from her father. The mutant protein was transmitted to patients 2 and 3, but patient 1 had a normal Pi M phenotype. The significance of this rare allele is not yet known (D Whitehouse, personal communication). Discussion A diagnosis of neonatal haemochromatosis was established in the five children reported here on histopathological and clinical grounds. At least 65 patients with NH have been observed and exhaustive reviews are available.459 The most important features are a high prevalence of prematurity (median gestational age 36 weeks, 55% <37 weeks), IUGR (median birth weight 2300 g, 60% <2500 g), early onset (88% during the first day), and an usually fulminating course of the liver dysfunction (median survival seven days, 80% dead <40 days using data from reference 5). Some typical cases of NH were diagnosed beyond the perinatal period.5
Longer survival was recently reported in early onset cases owing to more effective intensive care or desferrioxamine chelation, ' Deficiency of A4-3-oxosteroid 5-p-reductase was postulated in two unrelated patients'6 who presented with late onset liver insufficiency (1 and 6 weeks). Paucity of primary bile acids and a predominance of some derivatives of cholenoic acid were noted in the serum. Whether these represent a primary defect, or an anomaly secondary to the liver disease is still unknown. In the family described by jacknow et al,4 the mother and an affected surviving child were shown to have low serum transferrin and absent ferritin, so that a dominant mutation of ferritin with abnormal iron affinity and structure facilitating hepatic uptake was suggested to be causative. A single newborn was reported with NH, facial dysmorphism, complex cyanotic heart disease, syndactyly, and postaxial polydactyly." We have observed two sibs with delayed NH, intractable diarrhoea, facial dysmorphism, and hair anomalies.17A
NH is usually considered to be a recessive disorder. Recurrence of NH in sibships has been reported in at least 24 
